
Last update at 2026-06-09T15:57:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
BMO Capital Upgrades Celanese (CE) Stock, Cites Contributing Factors
Wed 21 May 25, 08:51 PMCelanese Plans to Divest Micromax Business to Deleverage
Thu 15 May 25, 03:00 PMCelanese First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Wed 07 May 25, 10:33 AMWhy Celanese Corporation (CE) Skyrocketed On Tuesday
Wed 07 May 25, 07:34 AMQ1 2025 Celanese Corp Earnings Call
Wed 07 May 25, 05:10 AMCelanese's Earnings and Revenues Surpass Estimates in Q1
Tue 06 May 25, 12:26 PMCelanese (CE) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Mon 05 May 25, 11:00 PMCelanese beats quarterly profit estimates; plans to spin off electronics segment
Mon 05 May 25, 10:13 PMCelanese (CE) Beats Q1 Earnings and Revenue Estimates
Mon 05 May 25, 10:10 PMCelanese Corporation Reports First Quarter Earnings
Mon 05 May 25, 08:55 PM| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -1220.00000M | -996.00000M | 1183.00M | 1421.00M | 2248.00M |
| Minority interest | -14.00000M | -8.00000M | -3.00000M | -8.00000M | -6.00000M |
| Net income | -1165.00000M | -1522.00000M | 1960.00M | 1894.00M | 1890.00M |
| Selling general administrative | 899.00M | 1030.00M | 1074.00M | 824.00M | 633.00M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 1791.00M | 2356.00M | 2603.00M | 2380.00M | 2682.00M |
| Reconciled depreciation | 786.00M | 823.00M | 704.00M | 62.00M | 25.00M |
| Ebit | -451.00000M | -320.00000M | 1903.00M | 1378.00M | 1946.00M |
| Ebitda | 292.00M | 503.00M | 2614.00M | 1751.00M | 2212.00M |
| Depreciation and amortization | 743.00M | 823.00M | 711.00M | 373.00M | 266.00M |
| Non operating income net other | - | - | - | 431.00M | 287.00M |
| Operating income | 767.00M | -697.00000M | 1687.00M | 1378.00M | 1946.00M |
| Other operating expenses | 8777.00M | 10977.00M | 9253.00M | 8291.00M | 6599.00M |
| Interest expense | 769.00M | 676.00M | 720.00M | 405.00M | 91.00M |
| Tax provision | -90.00000M | 510.00M | -1055.00000M | -489.00000M | 330.00M |
| Interest income | 496.00M | 33.00M | 60.00M | 69.00M | 201.00M |
| Net interest income | -745.00000M | -643.00000M | -657.00000M | -336.00000M | -92.00000M |
| Extraordinary items | -21.00000M | -8.00000M | -9.00000M | -8.00000M | -22.00000M |
| Non recurring | - | - | - | 8.00M | -3.00000M |
| Other items | - | - | - | - | - |
| Income tax expense | -90.00000M | 510.00M | -790.00000M | -489.00000M | 330.00M |
| Total revenue | 9544.00M | 10280.00M | 10940.00M | 9673.00M | 8537.00M |
| Total operating expenses | 1024.00M | 3053.00M | 916.00M | 998.00M | 744.00M |
| Cost of revenue | 7753.00M | 7924.00M | 8337.00M | 7293.00M | 5855.00M |
| Total other income expense net | -1987.00000M | -299.00000M | -504.00000M | 43.00M | 302.00M |
| Discontinued operations | - | - | - | -8.00000M | -22.00000M |
| Net income from continuing ops | -1130.00000M | -1506.00000M | 2036.00M | 1910.00M | 1918.00M |
| Net income applicable to common shares | -1165.00000M | -1522.00000M | 1960.00M | 1894.00M | 1890.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 21695.00M | 22857.00M | 26597.00M | 26272.00M | 11975.00M |
| Intangible assets | 3184.00M | 3641.00M | 3975.00M | 4105.00M | 735.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 743.00M | 285.00M | 272.00M | 241.00M | 70.00M |
| Total liab | 17223.00M | 17248.00M | 19045.00M | 20167.00M | 7438.00M |
| Total stockholder equity | 4049.00M | 5609.00M | 7091.00M | 5637.00M | 4189.00M |
| Deferred long term liab | - | - | - | 1242.00M | 555.00M |
| Other current liab | 940.00M | 1120.00M | 937.00M | 436.00M | 473.00M |
| Common stock | 0.17M | 0.02M | 0.02M | 0.02M | 0.02M |
| Capital stock | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Retained earnings | 9876.00M | 11100.00M | 12929.00M | 11274.00M | 9677.00M |
| Other liab | - | - | - | 2362.00M | 1557.00M |
| Good will | 4171.00M | 5387.00M | 6977.00M | 7142.00M | 1412.00M |
| Other assets | 1960.00M | 1806.00M | 2201.00M | 1355.00M | 769.00M |
| Cash | 1263.00M | 962.00M | 1805.00M | 1508.00M | 536.00M |
| Cash and equivalents | 1263.00M | 962.00M | 1805.00M | 1508.00M | 536.00M |
| Total current liabilities | 3683.00M | 3853.00M | 4072.00M | 4068.00M | 2505.00M |
| Current deferred revenue | - | - | 25.00M | 808.00M | 81.00M |
| Net debt | 11671.00M | 11617.00M | 12293.00M | 13535.00M | 3631.00M |
| Short term debt | 1275.00M | 1501.00M | 1472.00M | 1306.00M | 791.00M |
| Short long term debt | 1204.00M | 1501.00M | 1383.00M | 1306.00M | 791.00M |
| Short long term debt total | 12934.00M | 12952.00M | 14098.00M | 15043.00M | 4167.00M |
| Other stockholder equity | -5051.00000M | -5077.00000M | -5094.00000M | -5119.00000M | -5159.00000M |
| Property plant equipment | 5435.00M | 5661.00M | 6006.00M | 5584.00M | 4429.00M |
| Total current assets | 5693.00M | 5145.00M | 6218.00M | 6611.00M | 3807.00M |
| Long term investments | 1252.00M | 1217.00M | 1220.00M | 1062.00M | 823.00M |
| Net tangible assets | - | - | - | 6001.00M | 2042.00M |
| Short term investments | - | - | - | - | 10.00M |
| Net receivables | 1467.00M | 1614.00M | 1784.00M | 2054.00M | 1667.00M |
| Long term debt | 11394.00M | 11078.00M | 12301.00M | 13373.00M | 3176.00M |
| Inventory | 2220.00M | 2284.00M | 2357.00M | 2808.00M | 1524.00M |
| Accounts payable | 1279.00M | 1228.00M | 1510.00M | 1518.00M | 1160.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | 468.00M | 348.00M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -776.00000M | -848.00000M | -744.00000M | -518.00000M | -329.00000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | 11274.00M | 9677.00M |
| Treasury stock | - | - | - | -5491.00000M | -5492.00000M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 601.00M | 555.00M | 524.00M | 547.00M | 521.00M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 16002.00M | 17712.00M | 20379.00M | 19661.00M | 8168.00M |
| Capital lease obligations | 336.00M | 373.00M | 414.00M | 364.00M | 200.00M |
| Long term debt total | 11394.00M | 11078.00M | 12301.00M | 13373.00M | 3176.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -470.00000M | -10679.00000M | -11141.00000M | 516.00M |
| Change to liabilities | - | - | - | 328.00M | 355.00M |
| Total cashflows from investing activities | -349.00000M | -470.00000M | -134.00000M | -11141.00000M | -1119.00000M |
| Net borrowings | -323.00000M | -948.00000M | -1088.00000M | 10716.00M | 404.00M |
| Total cash from financing activities | -513.00000M | -1313.00000M | -1456.00000M | 10290.00M | -1042.00000M |
| Change to operating activities | - | - | - | 399.00M | -78.00000M |
| Net income | -1144.00000M | -1514.00000M | 1964.00M | 1902.00M | 1896.00M |
| Change in cash | 301.00M | -843.00000M | 297.00M | 972.00M | -419.00000M |
| Begin period cash flow | 962.00M | 1805.00M | 1508.00M | 536.00M | 955.00M |
| End period cash flow | 1263.00M | 962.00M | 1805.00M | 1508.00M | 536.00M |
| Total cash from operating activities | 1146.00M | 966.00M | 1899.00M | 1819.00M | 1757.00M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 777.00M | 823.00M | 711.00M | 478.00M | 378.00M |
| Other cashflows from investing activities | -27.00000M | -52.00000M | -98.00000M | -10598.00000M | -1168.00000M |
| Dividends paid | 13.00M | 307.00M | 305.00M | -297.00000M | -304.00000M |
| Change to inventory | 154.00M | 11.00M | 398.00M | -253.00000M | -367.00000M |
| Change to account receivables | 213.00M | 92.00M | 105.00M | 218.00M | -396.00000M |
| Sale purchase of stock | - | 1.00M | 0.00000M | -17.00000M | -1000.00000M |
| Other cashflows from financing activities | -177.00000M | -59.00000M | -63.00000M | 11130.00M | -142.00000M |
| Change to netincome | - | - | - | -837.00000M | 66.00M |
| Capital expenditures | 343.00M | 435.00M | 568.00M | 543.00M | 467.00M |
| Change receivables | - | - | - | 218.00M | -396.00000M |
| Cash flows other operating | - | - | - | -98.00000M | -216.00000M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | 968.00M | -404.00000M |
| Change in working capital | 235.00M | -204.00000M | 516.00M | 280.00M | -488.00000M |
| Stock based compensation | 24.00M | 32.00M | 40.00M | 60.00M | 95.00M |
| Other non cash items | 1556.00M | 1613.00M | -365.00000M | -66.00000M | -137.00000M |
| Free cash flow | 803.00M | 531.00M | 1331.00M | 1276.00M | 1290.00M |
Sector: Basic Materials Industry: Chemicals
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CE Celanese Corporation |
0.85 1.73% | 49.93 | - | 13.18 | 0.77 | 1.82 | 1.99 | 71.28 |
| SHECY Shin-Etsu Chemical Co Ltd ADR |
-0.82 3.74% | 21.08 | 18.83 | 12.18 | 0.03 | 2.62 | 0.03 | 0.06 |
| SHECF Shin-Etsu Chemical Co. Ltd |
-3.01 6.48% | 43.42 | 18.24 | 12.11 | 0.03 | 2.68 | 0.03 | 0.06 |
| BFFAF BASF SE NA O.N. |
-1.59 2.69% | 57.41 | 33.31 | 25.58 | 0.93 | 1.43 | 1.13 | 8.85 |
| BASFY BASF SE ADR |
-0.02 0.14% | 14.05 | 33.15 | 25.25 | 0.93 | 1.41 | 1.13 | 8.85 |
Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments. The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular weight polyethylene, and thermoplastic elastomers, polyesters, and vulcanizates for use in appliance, automotive, construction, consumer apparel, consumer electronics, electrical, energy storage, filtration equipment, industrial, medical, and telecommunication applications. It also provides acetic acid and anhydride, acetate flakes and tows, butyl acetates, emulsion polymers, ethyl acetates, ethylene vinyl acetate resins and compounds, formaldehydes, redispersible powders, and vinyl acetate monomers for use in adhesives, automotive parts, coatings, consumer goods, external thermal insulation composite systems, films, filtration, flexible packaging, food and beverage, food packaging, inks, lamination, lubricants, paints, paper finishing, pharmaceuticals, plasticizers, plasters and renders, solvents, textiles, and tiling applications. The company offers its products under the Amcel, AOPlus, Ateva, Avicor, Celanese, Celanex, Celanyl, Celcon, Celstran, Celvolit, Clarifoil, Crastin, Dur-O-Set, Dytron, ECOMID, EcoVAE, Elotex, Factor, Flexbond, Forprene, FRIANYL, Fortron, Geolast, GHR, GUR, Hostaform, Hytrel, Laprene, Melinex, MetaLX, Mowilith, MT, Mylar, NILAMID, Nylfor, OmniLon, Pibifor, Pibiter, Polifor, Resyn, Rynite, Santoprene, SlideX, Sofprene, Sofpur, Talcoprene, Tarnoform, Tecnoprene, TufCOR, Tynex, Vamac, VAntage, Vectra, Vinac, Vinamul, VitalDose, Zenite, and Zytel brands. It sells its products directly to customers and through distributors; and original equipment manufacturers and suppliers. Celanese Corporation was founded in 1912 and is headquartered in Irving, Texas.
222 W. Las Colinas Blvd., Irving, TX, United States, 75039-5421
| Name | Title | Year Born |
|---|---|---|
| Ms. Lori J. Ryerkerk BS | Chairman, Pres & CEO | 1963 |
| Mr. Scott A. Richardson | Exec. VP & CFO | 1977 |
| Ms. A. Lynne Puckett | Sr. VP, Gen. Counsel & Corp. Sec. | 1963 |
| Mr. John G. Fotheringham | Sr. VP of Acetyls (Leave of Absence) | 1969 |
| Mr. Thomas Francis Kelly | Sr. VP of Engineered Materials | 1965 |
| Mr. Aaron M. McGilvray | Chief Accounting Officer & VP | 1976 |
| Mr. Sameer Purao | VP & Chief Information Officer | NA |
| Ms. Vanessa A. Dupuis | Sr. VP & Chief HR Officer | 1974 |
| Mr. Jon Mortimer | Sr. VP of Global Manufacturing | NA |
| Ms. Ashley Duffie | VP & Chief Procurement Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.